Drug comparisons
Teplizumab vs Glyburide
Teplizumab (Tzield) vs Glyburide (Glynase): Delay T1D with immunotherapy or control T2D with sulfonylurea. Key diffs in use, safety (black box), suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when distinguishing T1D-delay immunotherapy from T2D sulfonylurea treatment.
Bottom line
Teplizumab and Glyburide treat entirely different diabetes types and stages so neither is universally superior.
All medication comparisons